Kerryn Pike
Kerryn Pike
Tracey Banivanua Mar Fellow, La Trobe University
Verified email at latrobe.edu.au - Homepage
Title
Cited by
Cited by
Year
Imaging β-amyloid burden in aging and dementia
CC Rowe, S Ng, U Ackermann, SJ Gong, K Pike, G Savage, TF Cowie, ...
Neurology 68 (20), 1718-1725, 2007
11352007
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
9322010
β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
KE Pike, G Savage, VL Villemagne, S Ng, SA Moss, P Maruff, CA Mathis, ...
Brain 130 (11), 2837-2844, 2007
8412007
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
7782011
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
CC Rowe, U Ackerman, W Browne, R Mulligan, KL Pike, G O'Keefe, ...
The Lancet Neurology 7 (2), 129-135, 2008
6602008
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of …
K Ellis, A Bush, D Darby, D De Fazio, J Foster, P Hudson, ...
Cambridge University Press, 2009
5632009
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
3702010
Subtypes of progressive aphasia: application of the international consensus criteria and validation using β-amyloid imaging
CE Leyton, VL Villemagne, S Savage, KE Pike, KJ Ballard, O Piguet, ...
Brain 134 (10), 3030-3043, 2011
3192011
Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
VL Villemagne, KE Pike, D Darby, P Maruff, G Savage, S Ng, ...
Neuropsychologia 46 (6), 1688-1697, 2008
2732008
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ...
Neurology 74 (2), 121-127, 2010
2332010
Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ...
Annals of neurology 74 (6), 905-913, 2013
1832013
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study
KE Pike, KA Ellis, VL Villemagne, N Good, G Chételat, D Ames, C Szoeke, ...
Neuropsychologia 49 (9), 2384-2390, 2011
1482011
Larger temporal volume in elderly with high versus low beta-amyloid deposition
G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ...
Brain 133 (11), 3349-3358, 2010
1322010
Larger temporal volume in elderly with high versus low beta-amyloid deposition
G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ...
Brain 133 (11), 3349-3358, 2010
1322010
The ART of loss: Aβ imaging in the evaluation of Alzheimer’s disease and other dementias
VL Villemagne, MT Fodero-Tavoletti, KE Pike, R Cappai, CL Masters, ...
Molecular neurobiology 38 (1), 1-15, 2008
1192008
Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease
G Chetelat, VL Villemagne, KE Pike, KA Ellis, P Bourgeat, G Jones, ...
Brain 134 (3), 798-807, 2011
1012011
Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease
G Verdile, SM Laws, D Henley, D Ames, AI Bush, KA Ellis, NG Faux, ...
Molecular psychiatry 19 (1), 69-75, 2014
932014
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging
J Fripp, P Bourgeat, O Acosta, P Raniga, M Modat, KE Pike, G Jones, ...
Neuroimage 43 (3), 430-439, 2008
892008
Blood-borne amyloid-β dimer correlates with clinical markers of Alzheimer's disease
VL Villemagne, KA Perez, KE Pike, WM Kok, CC Rowe, AR White, ...
Journal of Neuroscience 30 (18), 6315-6322, 2010
772010
Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study
A Bahar-Fuchs, G Chételat, VL Villemagne, S Moss, K Pike, CL Masters, ...
Journal of Alzheimer's Disease 22 (4), 1081-1087, 2010
712010
The system can't perform the operation now. Try again later.
Articles 1–20